Our research could not find a significant statistical association between EBV infection and breast IDC in Egyptian women attending our center, but, there might be an association between the existence of EBV and tumor aggressiveness.
Background: Papillary thyroid carcinoma is the most common thyroid neoplasm. It has a very high incidence of regional lymph node metastasis at the initial presentation. However, vascular spread is a very uncommon event. Lungs and bones are the most frequent sites of vascular metastasis from papillary thyroid carcinoma. Case concerns: The currently discussed case was obtained from the archive of Pathology laboratory, Sohag University. A 46-year-old female patient admitted to Urology Department, Sohag University, in 2015. The patient had a left loin pain, no other clinical data included in her referral sheet . Radiological findings revealed a renal mass and left radical nephrectomy was performed. Histopathological evaluation revealed a circumscribed neoplasm, formed of densely packed acini with scanty stroma. The patient was diagnosed as renal oncocytoma. On re-evaluation of the Hematoxylin and Eosin-stained slides; the nuclear features were different from those described in renal oncocytomas. So, a panel of immunohistochemical markers was performed (anti-CK7, anti-EMA, anti-Vimentin, anti-Thyroglobulin and anti-TTF1). Results: The neoplastic cells showed strong and diffuse cytoplasmic expression for Thyroglobulin and CK7 and nuclear expression for TTF1. The neoplastic cells didn’t express EMA or Vimentin. Based on the characteristic nuclear features detected by Hematoxylin and Eosin-stained slides and the obtained immunohistochemical results; the diagnosis of metastatic papillary thyroid carcinoma to the kidney was confirmed. Conclusions: Papillary thyroid carcinoma may metastasize to the kidney and form a solitary mass, that could be confused as a primary renal neoplasm.
Background: Distinguishing between pleural epithelioid mesothelioma, lung adenocarcinoma, and poorly differentiated squamous cell carcinoma (SCC) is a challenge in some cases. A panel of markers has been recommended by the International Mesothelioma Interest Group (IMIG) guideline to differentiate epithelioid mesothelioma from lung adenocarcinoma and SCC. However, the use of novel highly specific immunohistochemical (IHC) markers is still required. Objectives: This study aimed to evaluate glypican-1 (GPC1) expression in epithelioid mesothelioma, lung adenocarcinoma, and SCC, correlating its expression with some known clinicopathological parameters to clarify its diagnostic and prognostic value.Methods: This study included seventy specimens designated as 20 cases of pleural epithelioid mesothelioma, 30 cases of lung adenocarcinoma, and 20 cases of lung SCC. GPC1 expression was evaluated using immunohistochemistry (IHC). The data was analyzed statistically by SPSS software 25. GPC1 expression was correlated to different clinicopathologic data using Chi-square test. The study was conducted according to local Ethical Committee regulations. Results: This study detected positive GPC1 reactivity in all cases (100%) of pleural mesothelioma and lung SCC, in which increased GPC1 expression was correlated to large-sized, high grade, advanced stage tumors, and the presence of lymph node metastasis (LNM). In contrast, GPC1 expression was absent in about 93% of lung adenocarcinoma cases, and only 2 cases exhibited weak focal expression. Conclusion: Our findings demonstrated that GPC1 expression is upregulated in advanced pleural mesothelioma and pulmonary SCC; tumors with high GPC1 expression exhibited more advanced biological behavior.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.